U.S. enterprise employers are restructuring healthcare plans to manage escalating costs associated with GLP-1 weight-loss prescription coverage.
Cost Containment Measures
Pharmacy benefit managers report a 45% increase in spending on metabolic drugs year-to-date. In response, 38% of self-insured corporations have introduced strict lifestyle management prerequisites before authorizing coverage.
Long-term Financial Impact
Actuarial models suggest reduced long-term cardiovascular claims could offset current prescription costs within five to seven years, encouraging selective coverage retention.